AlphAIalphai — Financial news for AI agents
yahoo.comAUG 149 min read$TASK

TaskUs (TASK) Q2 2026 Earnings Call Transcript

TaskUs (TASK) held its Q2 2026 earnings call. It reported $309 million revenue, up 5% year over year and $10.9 million above the top end of guidance. Adjusted EBITDA was $57.7 million (18.7% margin), and adjusted free cash flow was $36.4 million, lifting cash to $180 million. Net leverage fell below 1.3x.

Original reporting
yahoo.com
Published Aug 14, 2026, 8:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 8:53 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
TaskUs (TASK) Q2 2026 Earnings Call Transcript — source image
Source · yahoo.com
Decision brief

The 30-second read

$TASKBullishMed
01

Why it matters

The call centers on quantified Q2 results (revenue, adjusted EBITDA, adjusted FCF, leverage) and forward-looking commentary for 2H 2026, including largest-client automation headwinds and service-line growth trajectories.

02

Market read

Traders can use the beat on revenue guidance and margin, plus the detailed segment and 2H 2026 headwind commentary, to reprice growth and risk assumptions.

03

What to watch

Trust and safety revenue is expected to keep declining YoY in 2H 2026 due to client automation; AI services growth is partly impacted in Q3 by sunsetting AI automation projects at social media clients.

Relevance 8/10Novelty 7/10Timing: pre-market today, earnings call transcript

Background

TaskUs held its Q2 2026 earnings call, introducing a new CFO and discussing segment performance, client concentration, and AI strategy execution.

Company-level read

Ticker impact

$TASKBullishMedium confidence
Context

TaskUs reports Q2 2026 revenue of $309M, adjusted EBITDA of $57.7M, and updates on 2026 outlook including largest-client headwinds.

Expected impact

Moderate positive bias, with potential volatility around largest-client decline and back-half 2026 headwinds.

Evidence & confidence

The transcript includes multiple quantified results (revenue, EBITDA, FCF, leverage) plus directional guidance for 2H 2026 and service-line trends, which are typically actionable for traders even without explicit EPS guidance in the excerpt.

Market effects

Sector

Reinforces demand resilience for AI-enabled customer experience and AI services within BPO/customer care, while highlighting ongoing automation pressure in social media trust-and-safety.

Regional

No clear regional market catalyst beyond mention of a robotics/physical AI training lab in Noida, India.

Global

Signals continued vendor consolidation and AI spend patterns among large global clients, relevant to outsourced CX and AI services demand.

Counterpoint

What could challenge this read

Largest-client revenue fell ~22% YoY and management flags additional 2H 2026 headwinds from automation and cost optimization, which could outweigh margin/FCF strength.

Key entities

  • company
    TaskUs

    Subject of the earnings call transcript, reporting Q2 2026 results and providing 2026 outlook commentary.

  • executive
    Rishabh Khemka

    New CFO making his first earnings call appearance and participating in financial walkthrough.

  • industry_analyst
    Everest Group

    Named as the source of a 2026 PEAK Matrix assessment for TaskUs health care customer experience management intelligent operations.

Read at source← All news

Related articles

AUG 5
$TASKHigh

TaskUs, Inc. (TASK): Results of Operations and Financial Condition

TaskUs, Inc. (TASK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsreleaseex991q22026.htm EX-99.1 Document Exhibit 99.1 TaskUs Announces Fiscal Second Quarter 2026 Results NEW BRAUNFELS, Texas, August 5, 2026 — TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced digital services and next-generation customer experience

SEC EDGAR 8-K6 min
AUG 14
$STKSMed

ONE Group (STKS) Q2 2026 Earnings Call Transcript

ONE Group (STKS) held its Q2 2026 earnings call. The company reported $33 million operating cash flow in the first six months of 2026 versus $11 million a year earlier, and reduced net capex by about 38% year to date. Total revenue was about $200 million, down 3.2% y/y, while consolidated restaurant-level operating margin rose to 16.4%. Comparable sales grew 0.9% for the quarter.

yahoo.com7 min
AUG 14
$NVSTHighAI 9/10

Envista (NVST) Q2 2026 Earnings Call Transcript

Envista (NVST) reported Q2 2026 results on an earnings call, citing 5% core growth and sales of $731 million. Adjusted gross margin rose to 55.1%, adjusted EBITDA grew 28% with 14.7% margin, and adjusted EPS was $0.41 (+58%). Free cash flow was $105 million. The company raised 2026 guidance: core growth 3.5% to 4.5%, adjusted EBITDA 11% to 14%, adjusted EPS $1.50 to $1.55.

yahoo.com12 min
AUG 14
$SWMRHighAI 9/10

Why is Swarmer stock sliding today?

Swarmer Inc (SWMR) shares fell about 8.5% pre-open to $39.35 after its Q2 2026 results. Revenue was about $220,000 (+56.5% YoY), but net loss widened to about $7.2M from $1.6M. Operating expenses rose about 777% to $7.5M. The company gave no formal revenue guidance, while citing a $14.2M SkyKnight contract and ~$25.3M cash.

investing.com4 min
AUG 14
$EXPEHighAI 9/10

Expedia (EXPE) Q2 2026 Earnings Call Transcript

Expedia Group (EXPE) reported Q2 2026 results, saying it exceeded the high end of guidance for the fifth quarter in a row. Bookings rose 12%, revenue rose 14%, and adjusted EBITDA was $1.1 billion (25.9% margin). Adjusted EPS grew 36% and trailing 12-month free cash flow was $4.5 billion. The company raised full-year guidance and discussed AI, B2B growth, and acquisitions (Layla) and planned CarTrawler.

yahoo.com7 min
AUG 14
$HUMAMed

Humacyte, Inc. Q2 2026 Earnings Call Summary

Humacyte reported Q2 2026 updates on Symvess uptake and pipeline progress. Management cited slower adoption due to underestimated education needs and rebuilt its sales team. Phase III V012 in female dialysis patients showed 91 more catheter-free days vs standard of care. Humacyte plans an sBLA filing for dialysis in Nov 2026, targeting PDUFA May 2027. Cash was $80.1M at June 30, 2026.

yahoo.com6 min